Home › Targets › miR-124

miR-124 (1 companies · 2 programs)

Companies with an active program directed at miR-124.

Abivax S.A. ABVX

  • obefazimod — Ulcerative Colitis Phase 3
  • obefazimod — Crohn's Disease Phase 2